Main
>
ONCOLOGY (**)
>
Leukemia>Lymphoblastic>Acute>Ph+***
>
Treatment
>
Co.: IN. S. Generic Imatinib *
>
USA Approval Date: 2016. 02.01.
USA Approval Date: 2016. 02.01.'s products
This section has no products